Mi Tratamiento
Store data observed · From public App Store data · How we score apps
- Medical
- App Store
- United States
- —0 ratings
- Free download
- Updated
- Observed
Ratings
Observed0
Chart position
Observed—Not on the top charts
90-day growth
—not enough history yet
Opportunity score
AI-derived0/100Weak · low confidence
Own Mi Tratamiento? Share your real numbers
Your numbers stay private. They only tune MRRBeam's estimates, so every app's figures get more accurate.
Sign in to share them.
Made Mi Tratamiento? Add a “Tracked in Medical” badge to your site
About Mi TratamientoObserved
Mi Tratamiento is a Medical app by Osakidetza on the United States App Store. Released Dec 19, 2016; last updated Sep 24, 2026 (version 6.1.0). Mi Tratamiento is free to download.
MRRBeam rates the success of Mi Tratamiento 0/100 (early stage).
Aplicación para consultar tu Tratamiento Activo en Osakidetza, donde se incluye la medicación prescrita para su recogida en la farmacia.
- Success score
- 0/100 Early stage
- In Medical
- Outside the top 100
- Chart position
- Not on the top charts
- Developer
- Osakidetza
Loading the full report…
Mi Tratamiento: common questions
- What is Mi Tratamiento?
- Mi Tratamiento is a Medical app developed by Osakidetza, available on the App Store. It was first released on Dec 19, 2016.
- How much does Mi Tratamiento cost?
- Mi Tratamiento is free to download.
- Is Mi Tratamiento successful?
- MRRBeam rates the success of Mi Tratamiento 0/100 (early stage). The success score combines rating volume, chart position and average rating.
- When was Mi Tratamiento last updated?
- Mi Tratamiento was last updated on Sep 24, 2026 (version 6.1.0).
- What are alternatives to Mi Tratamiento?
- Similar Medical apps tracked by MRRBeam include CVS Health, MyChart, healow, UnitedHealthcare and GoodRx: Prescription Savings.
- Is there room to build a competitor to Mi Tratamiento?
- MRRBeam's opportunity score for Mi Tratamiento is 0/100. Limited opening: an older app, little observable demand and a crowded category with entrenched leaders.